ReP USP - Resultado da busca

Artigo de periodico
Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model (2021)
Jesus, Suzana Marques de; Pinto, Leonardo; Moreira, Fernanda de Lima ; Nardotto, Glauco Henrique Balthazar ; Cristofoletti, Rodrigo; Perin, Luísa; Fonseca, Kátia da Silva; Barbêdo, Pauliana; Bandeira, Lorena Cera; Vieira, Paula Melo de Abreu; Carneiro, Claudia Martins
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCFRP
Subjects: DOENÇA DE CHAGAS, FARMACOCINÉTICA, TRYPANOSOMA CRUZI, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Suzana Marques de et al. Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model. Antimicrobial Agents and Chemotherapy, v. 65, n. 2, p. e01383-20, 2021Tradução . . Disponível em: https://doi.org/10.1128/AAC.01383-20. Acesso em: 27 nov. 2025.
APA
Jesus, S. M. de, Pinto, L., Moreira, F. de L., Nardotto, G. H. B., Cristofoletti, R., Perin, L., et al. (2021). Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model. Antimicrobial Agents and Chemotherapy, 65( 2), e01383-20. doi:10.1128/AAC.01383-20
NLM
Jesus SM de, Pinto L, Moreira F de L, Nardotto GHB, Cristofoletti R, Perin L, Fonseca K da S, Barbêdo P, Bandeira LC, Vieira PM de A, Carneiro CM. Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 2): e01383-20.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.01383-20
Vancouver
Jesus SM de, Pinto L, Moreira F de L, Nardotto GHB, Cristofoletti R, Perin L, Fonseca K da S, Barbêdo P, Bandeira LC, Vieira PM de A, Carneiro CM. Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse–berenice-78 Trypanosoma cruzi strain model [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 2): e01383-20.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.01383-20
Artigo de periodico
Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria (2021)
Rodriguez, Adriana Alejandra Marin; Murillo, Oscar ; Sussmann, Rodrigo Antonio Ceschini ; Ortolan, Luana S. ; Battagello, Daniella Sabino ; Quirino, Thatyane de Castro ; Bittencourt, Jackson Cioni ; Epiphanio, Sabrina ; Katzin, Alejandro Miguel ; Carvalho, Leonardo José de Moura
Source: Antimicrobial Agents and Chemotherapy. Unidades: ICB, FCF
Subjects: MALÁRIA, ÁLCOOL, ADJUVANTES IMUNOLÓGICOS, ANATOMIA, PARASITOLOGIA, CAMUNDONGOS, CÉLULAS ENDOTELIAIS, FARMACOCINÉTICA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUEZ, Adriana Alejandra Marin et al. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, v. 65, n. 5, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1128/AAC.00004-21. Acesso em: 27 nov. 2025.
APA
Rodriguez, A. A. M., Murillo, O., Sussmann, R. A. C., Ortolan, L. S., Battagello, D. S., Quirino, T. de C., et al. (2021). Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria. Antimicrobial Agents and Chemotherapy, 65( 5), 1-14. doi:10.1128/AAC.00004-21
NLM
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJ de M. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.00004-21
Vancouver
Rodriguez AAM, Murillo O, Sussmann RAC, Ortolan LS, Battagello DS, Quirino T de C, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJ de M. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria [Internet]. Antimicrobial Agents and Chemotherapy. 2021 ; 65( 5): 1-14.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.00004-21
Artigo de periodico
Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment (2013)
Serafim, Eliana Ometto Pavan; Silva, Antonio Távora de Albuquerque; Moreno, Andréia de Haro; Vizioli, Ednir de Oliveira; Ferreira, Elizabeth Igne ; Peccinini, Rosângela Gonçalves; Ribeiro, Maria Lúcia; Chung, Man Chin
Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, ENZIMAS, DOENÇA DE CHAGAS (TRATAMENTO), FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Eliana Ometto Pavan et al. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment. Antimicrobial Agents and Chemotherapy, v. 57, n. 12, p. 6106-6109, 2013Tradução . . Disponível em: https://doi.org/10.1128/AAC.02522-12. Acesso em: 27 nov. 2025.
APA
Serafim, E. O. P., Silva, A. T. de A., Moreno, A. de H., Vizioli, E. de O., Ferreira, E. I., Peccinini, R. G., et al. (2013). Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment. Antimicrobial Agents and Chemotherapy, 57( 12), 6106-6109. doi:10.1128/AAC.02522-12
NLM
Serafim EOP, Silva AT de A, Moreno A de H, Vizioli E de O, Ferreira EI, Peccinini RG, Ribeiro ML, Chung MC. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment [Internet]. Antimicrobial Agents and Chemotherapy. 2013 ; 57( 12): 6106-6109.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.02522-12
Vancouver
Serafim EOP, Silva AT de A, Moreno A de H, Vizioli E de O, Ferreira EI, Peccinini RG, Ribeiro ML, Chung MC. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment [Internet]. Antimicrobial Agents and Chemotherapy. 2013 ; 57( 12): 6106-6109.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1128/AAC.02522-12

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em